Recombinant Human Thioredoxin-1 Protects Macrophages from Oxidized Low-Density Lipoprotein-Induced Foam Cell Formation and Cell Apoptosis = Recombinant Human Thioredoxin-1 Protects Macrophages from Oxidized Low-Density Lipoprotein-Induced Foam Cell Formation and Cell Apoptosis

다국어 초록 (Multilingual Abstract)

Oxidized low-density lipoprotein (ox-LDL)-induced macrophage foam cell formation and apoptosis play critical roles in the pathogenesis of atherosclerosis. Thioredoxin-1 (Trx) is an antioxidant that potently protects various cells from oxidative stress-induced cell death. However, the protective effect of Trx on ox-LDL-induced macrophage foam cell formation and apoptosis has not been studied. This study aims to investigate the effect of recombinant human Trx (rhTrx) on ox-LDL-stimulated RAW264.7 macrophages and elucidate the possible mechanisms. RhTrx significantly inhibited ox-LDL-induced cholesterol accumulation and apoptosis in RAW264.7 macrophages. RhTrx also suppressed the ox-LDL-induced overproduction of lectin-like oxidized LDL receptor (LOX- 1), Bax and activated caspase-3, but it increased the expression of Bcl-2. In addition, rhTrx markedly inhibited the ox-LDL-induced production of intracellular reactive oxygen species (ROS) and phosphorylation of p38 mitogen-activated protein kinases (MAPK). Furthermore, anisomycin (a p38 MAPK activator) abolished the protective effect of rhTrx on ox-LDL-stimulated RAW264.7 cells, and SB203580 (a p38 MAPK inhibitor) exerted a similar effect as rhTrx. Collectively, these findings indicate that rhTrx suppresses ox-LDL-stimulated foam cell formation and macrophage apoptosis by inhibiting ROS generation, p38 MAPK activation and LOX-1 expression. Therefore, we propose that rhTrx has therapeutic potential in the prevention and treatment of atherosclerosis.

참고문헌 (Reference)

1 Gleissner, C. A., "Translational atherosclerosis research: from experimental models to coronary artery disease in humans" 248 : 110-116, 2016

2 Kamimoto, Y., "Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy" 53 : 2046-2055, 2010

3 Yamawaki, H., "Thioredoxin: a key regulator of cardiovascular homeostasis" 93 : 1029-1033, 2003

4 Hsieh, C. C., "Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice" 20 : 259-268, 2006

5 Chen, G., "Thioredoxin-1 increases survival in sepsis by inflammatory response through suppressing endoplasmic reticulum stress" 46 : 67-74, 2016

6 Tao, L., "Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress" 149 : 311-318, 2006

7 Holmgren, A., "Thioredoxin" 54 : 237-271, 1985

8 Dunn, S., "The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease" 409 : 349-355, 2008

9 Dai, M. X., "The impact of intermittent and repetitive cold stress exposure on endoplasmic reticulum stress and instability of atherosclerotic plaques" 34 : 393-404, 2014

10 Yoshimoto, R., "The discovery of LOX-1, its ligands and clinical significance" 25 : 379-391, 2011

11 D’Annunzio, V., "Role of thioredoxin-1 in ischemic preconditioning, postconditioning and aged ischemic hearts" 109 : 24-31, 2016

12 Guo, R., "Resveratrol suppresses oxidised low-density lipoprotein-induced macrophage apoptosis through inhibition of intracellular reactive oxygen species generation, LOX-1, and the p38 MAPK pathway" 34 : 603-616, 2014

13 Wang, W. L., "Reduced beta2-glycoprotein I protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis" 12 : 174-, 2013

14 Lin, Y. W., "RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages" 79 : 287-294, 2015

15 Powis, G., "Properties and biological activities of thioredoxins" 30 : 421-455, 2001

16 Ishiyama, J., "Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells" 209 : 118-124, 2010

17 Inoue, K., "Over-expression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice" 97 : 176-184, 2005

18 Cuadrado, A., "Mechanisms and functions of p38 MAPK signalling" 429 : 403-417, 2010

19 Seimon, T., "Mechanisms and consequences of macrophage apoptosis in atherosclerosis" 50 (50): S382-S387, 2009

20 Saitoh, M., "Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1" 17 : 2596-2606, 1998

21 Moore, K. J., "Macrophages in the pathogenesis of atherosclerosis" 145 : 341-355, 2011

22 Moore, K. J., "Macrophages in atherosclerosis: a dynamic balance" 13 : 709-721, 2013

23 Tabas, I., "Macrophage death and defective inflammation resolution in atherosclerosis" 10 : 36-46, 2010

24 Liao, X., "Macrophage autophagy plays a protective role in advanced atherosclerosis" 15 : 545-553, 2012

25 Tabas, I., "Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress" 11 : 2333-2339, 2009

26 Pirillo, A., "LOX-1, OxLDL, and atherosclerosis" 2013 : 152786-, 2013

27 Schaeffer, D. F., "LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma" 50 : 1676-1684, 2009

28 Luo, Y., "Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction" 10 : e0120259-, 2015

29 Wang, B., "Intraperitoneal administration of thioredoxin decreases brain damage from ischemic stroke" 1615 : 89-97, 2015

30 Xia, X., "Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice" 5 : 23-, 2015

31 Kataoka, H., "Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions" 99 : 3110-3117, 1999

32 Cohen, J. I., "Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver" 49 : 1709-1717, 2009

33 Laurent, T. C., "Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from escherichia coli B" 239 : 3436-3444, 1964

34 Matsui, M., "Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene" 178 : 179-185, 1996

35 Mehta, J. L., "Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet" 100 : 1634-1642, 2007

36 Janicke, R. U., "Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis" 273 : 9357-9360, 1998

37 Rusinol, A. E., "AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis" 279 : 1392-1399, 2004